GlobeNewswire

LeddarTech Delivers Production Samples of the LeddarCore LCA2 System-on-Chip for Mass-Market Automotive LiDARs

Del

LeddarCore LCA2 production samples demonstrate enhanced LiDAR performance and resolution with a SoC and software designed to meet functional safety requirements.

QUEBEC CITY, Jan. 07, 2019 (GLOBE NEWSWIRE) -- LeddarTech, an industry leader providing the most versatile and scalable auto and mobility LiDAR platform, announces the availability of production samples of the LeddarCore LCA2 system-on-chip (SoC), which offers enhanced LiDAR performance and resolution in a design that conforms to functional safety requirements. The LCA2 SoC allows Tier-1 suppliers to design and mass produce automotive-grade solid-state LiDARs at costs ranging from sub-100$ for entry-level solutions to sub-300$ for high-performance solutions, making the cost-effective deployment of LiDARs in production vehicles possible.

“With the production version of the LCA2 system-on-chip, we can achieve a significantly longer range than originally planned—with more than 100m at 10% reflectivity. We also added the support of Hybrid Flash designs that use microelectromechanical systems (MEMS) for laser beam steering, which increases the resolution,” said Michael Poulin, vice-president of product management at LeddarTech. “The LCA2’s SoC and software have been designed from the ground up to meet ISO 26262 ASIL-B and will allow our customers to deliver automotive-grade LiDARs that comply with functional safety requirements,” concluded Mr. Poulin. 

The LCA2 LeddarEngine, comprised of the LeddarCore LCA2 SoC and LeddarSP signal processing software library, is at the core of LeddarTech’s auto and mobility LiDAR platform, which equips key suppliers of components and systems with the technology, tools and resources they need to design their own differentiated LiDAR offering and to meet the specific requirements of various advanced driver-assistance systems (ADAS) and autonomous driving (AD) applications, including:

  • Passenger car ADAS and AD (such as Traffic Jam Pilot)  
  • Commercial vehicle ADAS and AD
  • Autonomous shuttles and autonomous delivery vehicles
  • Robotaxi 360° AD LiDAR cocoon

The Scalable, Versatile Auto & Mobility LiDAR Platform

With its ability to support various types of designs and components, including many options of light sources and wavelengths, photodetectors, illumination and beam steering methods, the LCA2 LeddarEngine enables and enhances multiple solid-state LiDAR methods, including Flash and MEMS Hybrid Flash configurations. Hence, the LCA2 LeddarEngine is a key component of a highly versatile and scalable platform that can address a wide range of automotive and mobility applications.

The platform leverages affordable, readily available technologies and is supported by the Leddar Ecosystem of partners who have developed automotive-grade components, software and tools that are ready to be used in the development of cost-effective SSLs based on the LeddarEngine. This shortens development cycles and accelerates the path to high-volume manufacturing, making the LeddarEngine the best LiDAR solution to meet the accelerated mass-market ramp-up. 

The LCA2 LeddarEngine integrates LeddarTech’s proprietary signal acquisition and processing algorithms. The powerful Leddar technology, which has been perfected over a decade of dedicated R&D and multiple commercial deployments in the most demanding environments, enhances LiDAR’s detection range and accuracy, for optimized performance-to-cost ratios.

LiDAR sensor implementations of the newly released LCA2 SoC will be demonstrated at CES 2019 in Las Vegas, January 8 to 11, at the LeddarTech Pavilion found at CP-16.

About LeddarTech
LeddarTech is an industry leader providing the most versatile, scalable auto and mobility LiDAR platform based on the unique LeddarEngine, which consists of a suite of automotive-grade, functional safety certified SoCs working in tandem with LeddarSP signal processing software. The company is responsible for several innovations in cutting-edge mobility remote-sensing applications, its patented technologies enhancing ADAS and autonomous driving capabilities for automobiles, trucks, buses, delivery vehicles, robotaxis, shuttles, and more. Additional information about LeddarTech is accessible at www.LeddarTech.com, and on LinkedIn, Twitter, Facebook and Youtube.

LeddarTech, Leddar, LeddarEngine, LeddarSP, and LeddarTech logos are trademarks or registered trademarks of LeddarTech Inc. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

A video accompanying this release is available at: http://www.globenewswire.com/NewsRoom/AttachmentNg/41c79f71-e728-4295-b62e-782e4c9234bf

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Oxford Immunotec Announces Chief Financial Officer Transition21.3.2019 21:01:00 CETPressemelding

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that Richard Altieri, the Company’s Chief Financial Officer (CFO), will retire on April 30, 2019. The Company has appointed Matthew McLaughlin, currently Chief Financial Officer, GE Healthcare – U.S. and Canada, as his successor. Mr. McLaughlin will join Oxford Immunotec as CFO on April 8, 2019. Today’s announcement concludes an extensive search process conducted by the Company. As part of the planned succession, Mr. Altieri, who has led Oxford Immunotec’s global finance organization as CFO since 2012, will remain an active member of the Company’s management team until his retirement date. “During his seven year tenure, Rick successfully managed multiple financing rounds, including the Company's IPO, the acquisition and financial integration of three companies and, most recently, the dives

Blackhawks, Flyers, Sabres and Lightning Headline the 2019 NHL Global Series21.3.2019 15:34:00 CETPressemelding

Chicago Blackhawks and Philadelphia Flyers to Open Regular Season in Prague, Czech Republic on Oct. 4 Buffalo Sabres and Tampa Bay Lightning to Face Off in a Pair of Games in Stockholm, Sweden on Nov. 8 and Nov. 9 2019 NHL Global Series Challenge to feature Blackhawks vs. Eisbären Berlin on Sept. 29 in Berlin, Germany and Flyers vs. Lausanne HC on Sept. 30 in Lausanne, Switzerland Tickets to Games in Berlin, Prague and Stockholm Available for Purchase on Wednesday, March 27; Tickets to Game in Lausanne Available for Purchase on Wednesday, April 10 NEW YORK/TORONTO, March 21, 2019 (GLOBE NEWSWIRE) -- The National Hockey League (NHL) and the National Hockey League Players’ Association (NHLPA), in conjunction with Live Nation Sweden, today announced that the Buffalo Sabres, Chicago Blackhawks, Philadelphia Flyers and Tampa Bay Lightning will participate in the 2019 NHL Global Series. The Chicago Blackhawks and Philadelphia Flyers will play their 2019-20 season-opening game against each ot

Farmako: World's Largest Import Contract for Pharmaceutical Cannabis21.3.2019 15:10:00 CETPressemelding

German Farmako secures 50 tonnes of flowers and oils from Polish company Pharmacann Polska FRANKFURT, March 21, 2019 (GLOBE NEWSWIRE) -- Farmako will import 50 tonnes of pharmaceutical cannabis from Pharmacann Polska into the European market over the next four years. This provides the basis for a reliable supply of pharmaceutical cannabis for millions of patients in the European healthcare system. The company expects a total revenue of several hundred million Euros from the agreed exclusive partnership. Founded in September 2018, Farmako now has grown to 40 employees and is distributing high-quality pharmaceutical cannabis to German pharmacies since March 2019. This is the biggest Cannabis contract to date, and the first big contract without participation of a Canadian LP. Farmako has signed an exclusive and binding agreement to import and distribute 50 tons of pharmaceutical cannabis over four years. Farmako and Pharmacann Polska enter strategic partnership to develop custom tailored

NexOptic Appoints Rich Geruson, Former Lexmark CEO, to Board of Directors21.3.2019 14:00:00 CETPressemelding

VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- NexOptic Technology Corp. ("NexOptic" or the "Company") (TSX VENTURE: NXO) (OTCQX: NXOPF) (FRANKFURT: E3O1) is pleased to announce that Richard J. (Rich) Geruson has joined its Board of Directors, effective immediately. Mr. Geruson’s experience spans CEO roles at Lexmark International, Phoenix Technologies and VoiceSignal Technologies, and Senior Vice President and executive positions at Nokia, IBM, Toshiba, and McKinsey & Co. As CEO of Lexmark International, a multibillion-dollar imaging technology and solutions company with 10,000 employees, he grew printer sales faster than at any time in the preceding 10 years while simultaneously executing extensive process reengineering, transforming the business from negative EBITDA and high debt to positive multi-hundred-million-dollar EBITDA and a healthy debt profile. While CEO of Phoenix Technologies, he achieved consistently high profit year-over-year for six years straight in

Standard Lithium Announces Closing of $11.4 Million Bought Deal Including Partial Exercise of Over-Allotment Option21.3.2019 14:00:00 CETPressemelding

VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLL) (OTCQX: STLHF) (FRA: S5L) is pleased to announce that it has closed its previously announced bought deal offering (the “Offering”), including the partial exercise of the over-allotment option. A total of 11,390,500 units (the “Units”) of the Company were issued at a price of $1.00 per Unit for gross proceeds of $11,390,500. Each Unit is comprised of one common share and one-half of one common share purchase warrant of the Company (each whole common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company at an exercise price of $1.30 per share, subject to adjustment in certain events, until March 21, 2022. The Units were offered and sold by way of a short form prospectus filed in each of the provinces of ‎Canada, excluding Quebec, and offered and sold elsewhere outside of Canada on a private placement